Amit Akirov

Tel Aviv University — Israel

Medicine · Health Sciences

25h-index2.2kcitations114works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pituitary Gland Disorders and Treatments(51), Growth Hormone and Insulin-like Growth Factors(32), Adrenal and Paraganglionic Tumors(28), Hyperglycemia and glycemic control in critically ill and hospitalized patients(16), Adrenal Hormones and Disorders(15)

Publications114 total

Hypercoagulability in Cushing’s syndrome: past, present, future
Archives of Endocrinology and Metabolism·2026Open Access
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
The Lancet Diabetes & Endocrinology·2025· 1 citedOpen Access
Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study
Pituitary·2025· 1 cited
Patients with langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort
Pituitary·2025Open Access
Prolactin-secreting adenomas: pathogenesis, diagnosis, and management
The Lancet Diabetes & Endocrinology·2025· 14 cited
Weight gain reversibility and BMI following treatment for Cushing’s syndrome: long-term outcomes and potential predictors
Pituitary·2025· 2 cited
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Nature Reviews Endocrinology·2025· 16 citedOpen Access
Predictors of cancer in patients with endogenous Cushing’s syndrome
Endocrine Related Cancer·2025· 1 cited
Response to cabergoline treatment, gonadal axis recovery, and outcomes of drug withdrawal, in men with microprolactinoma: a retrospective cohort study
Endocrine·2025· 7 citedOpen Access
Mortality in Cushing's syndrome: declining over 2 decades but remaining higher than the general population
European Journal of Endocrinology·2025· 8 citedOpen Access
Impact of remission status in endogenous Cushing's syndrome on cancer incidence
European Journal of Endocrinology·2025· 2 cited
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus
Diabetes & Metabolism·2025· 8 citedOpen Access
Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus
Diabetes & Metabolism·2025· 7 citedOpen Access
Ischemic stroke risk in patients with dopamine agonist‐treated hyperprolactinemia
Journal of Neuroendocrinology·2025· 3 citedOpen Access
Leukocytosis in Cushing’s syndrome persists post-surgical remission and could predict a lower remission prognosis in patients with Cushing’s disease
Journal of Endocrinological Investigation·2025· 1 citedOpen Access
Cushing’s syndrome related to higher rates and earlier onset of cataract: A nationwide retrospective cohort study
Graefe s Archive for Clinical and Experimental Ophthalmology·2025
Author response for "Ischemic stroke risk in patients with dopamine agonist‐treated hyperprolactinemia"
2025
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis
Pituitary·2024· 5 cited
Higher risk and earlier onset glaucoma in Cushing's syndrome
Acta Ophthalmologica·2024· 2 citedOpen Access
Breast Cancer risk in patients with dopamine agonist-treated hyperprolactinemia
Journal of Endocrinological Investigation·2024· 4 cited
page 1 of 6Next →

Frequent Co-authors

Ilan Shimon(34), Tzippy Shochat(13), Talia Diker‐Cohen(12), Eyal Robenshtok(10), Hiba Masri‐Iraqi(9), Dania Hirsch(9), Alexander Gorshtein(9), Shereen Ezzat(8), Gloria Tsvetov(8), Vincent Larouche(6), Hadar Duskin‐Bitan(6), Idit Dotan(6), Alon Grossman(4), L. Sylvia(4), Carlos Benbassat(4), Yossi Manisterski(4), Yaron Rudman(4), Oren Amitai(3), Ilana Shraga-Slutzky(3), Yoav Eizenberg(3)